Keyphrases
Antileukemic Activity
100%
Statins
100%
3-hydroxy-3-methylglutaryl-coenzyme A
100%
Reductase Inhibitors
100%
Leukemia
40%
Cholesterol
40%
Apoptosis
20%
Immune System
20%
Therapeutic Potential
20%
Acute Myeloid Leukemia
20%
Signaling Molecules
20%
In Vitro Study
20%
Clinical Data
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Early Phase Clinical Trials
20%
Cell Differentiation
20%
Conventional Chemotherapy
20%
Chemotherapy Regimen
20%
Deprivation
20%
Isoprenylation
20%
Mevalonate Pathway
20%
Inhibits Proliferation
20%
Geranylgeranyl Pyrophosphate
20%
Farnesyl Pyrophosphate
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
HMG-CoA
100%
Oxidoreductase
100%
Leukemia
40%
Clinical Study
20%
Preclinical Study
20%
Chemotherapy
20%
Side Effect
20%
Mevalonic Acid
20%
Farnesyl Diphosphate
20%
Geranylgeranyl Pyrophosphate
20%
Acute Myeloid Leukemia
20%